Thrombolytic therapy for acute ischaemic stroke: promising, perilous, or unproven?

Affiliations

Comment

P Sandercock. Lancet. 1995.

. 1995 Dec 9;346(8989):1504-5.

doi: 10.1016/s0140-6736(95)92044-7.

No abstract available

Comment in

Multicentre Acute Stroke Trial--Italy.
Muir KW. Muir KW. Lancet. 1996 Feb 10;347(8998):391; author reply 393. Lancet. 1996. PMID: 8598711 Clinical Trial. No abstract available.
Multicentre Acute Stroke Trial--Italy.
Barer D. Barer D. Lancet. 1996 Feb 10;347(8998):391-2; author reply 393. Lancet. 1996. PMID: 8598712 Clinical Trial. No abstract available.

Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke. Multicentre Acute Stroke Trial--Italy (MAST-I) Group.
[No authors listed] [No authors listed] Lancet. 1995 Dec 9;346(8989):1509-14. Lancet. 1995. PMID: 7491044 Clinical Trial.
Dissent: an alternative interpretation of MAST-I. Multicentre Acute Stroke Trial--Italy Group.
Tognoni G, Roncaglioni MC. Tognoni G, et al. Lancet. 1995 Dec 9;346(8989):1515. doi: 10.1016/s0140-6736(95)92050-1. Lancet. 1995. PMID: 7491045 No abstract available.